11/30/2000 | Imazalil: Response to the Registrant's Comments to the Human Health Risk Assessments and Science Chapter Reviews. DP Barcode D270787. Submission No.: S582653 (PDF, 6 pp, 85K) | Abdallah Khasawinah | Reregistration Branch 4 HED | - |
11/13/2000 | IMAZALIL: Re-define the Short Term Dermal Exposure for Assessing Seed Treatment Exposure Scenario. Tox review 014374. (PDF, 2 pp, 47K) | Abdallah Khasawinah | Reregistration Branch HED | - |
02/09/2000 | Imazalil: The HED Toxicology Chapter for the Reregistration Eligibility Decision Document (RED) (PDF, 43 pp, 803K) | Abdallah Khasawinah | Reregistration Branch 4 HED | - |
02/08/2000 | Supplement to Document No. 004853 - DER for Accession No. 000258128: Oral Embryotoxicity and Teratogenicity of Imazalil in Cobs Mice. (PDF, 3 pp, 25K) | Abdallah Khasawinah | Reregistration Branch 4 HED | - |
02/08/2000 | Supplement to Document No. 007865 - DER for MRID No. 41026603: Embryotoxicity and Teratogenicity Study in Sprague Dawley Rats (Imazalil Sulphate 27180) (PDF, 3 pp, 30K) | Abdallah Khasawinah | Reregistration Branch 4 HED | - |
02/08/2000 | Supplement to HED Document No. 000065 & 007865 - DER for Accession No. 097233 (amendment MRID No. 41026604): 3- Generation Reproduction Study in Rats. (PDF, 3 pp, 38K) | Abdallah Khasawinah | Reregistration Branch 4 HED | - |
02/08/2000 | Supplement to Document No. 010278 and 011019 - DER for MRID 42570701: 2-Generation Reproduction Study in Rats. (PDF, 4 pp, 51K) | Abdallah Khasawinah | Reregistration Branch 4 HED | - |
02/08/2000 | Imazalil: Review and Update of Toxicology Studies to Support Re-registration Eligibility Decision (PDF, 17 pp, 273K) | Abdallah Khasawinah | Reregistration Branch 4 HED | - |
01/06/2000 | Imazalil: Evaluation of Supplementary Data to Combined Chronic/Carcinogenicity Study in Rats and Evaluation of Teratogenicity Studies in Mice MRIDs 448558001, 44567801, 445678703, 44567802. (PDF, 3 pp, 39K) | Abdallah Khasawinah | Reregistration Branch 4 HED | - |
12/07/1999 | Imazalil - 3rd Report of the Cancer Assessment Review Committee. Tox review 013885. (PDF, 13 pp, 412K) | Sanjivani Diwan | Health Effects Division | - |
10/04/1999 | IMAZALIL: - Reassessment of the Requirement for a Developmental Neurotoxicity Study in Rats- Report of the Hazard Identification Assessment Review Committee. Tox review 013778. (PDF, 8 pp, 198K) | Abdallah Khasawinah | Reregistration Branch HED | - |
09/28/1999 | IMAZALIL - Report of the Safety Factor Committee. Tox review 013762. (PDF, 5 pp, 193K) | Brenda Tarplee | Health Effects Division | - |
06/29/1999 | IMAZALIL: - Report of the Hazard Identification Assessment Review Committee. Tox review 013539. (PDF, 20 pp, 773K) | Abdallah Khasawinah | Reregistration Branch HED | - |
09/04/1998 | Cancer Assessment Document. Second Evaluation of the Carcinogenic Potential of Imazalil. Tox review 012870. (PDF, 42 pp, 2MB) | Edwin Budd | Health Effects Division | - |
09/14/1996 | PP 7F03530, Imazalil, Adequacy of submitted data with Regard to second Carcinogenicity peer review. DP Barcode: D225180 (PDF, 17 pp, 423K) | Edwin R. Budd | Toxicology Branch I | - |